Melatonin: What the Research Says

What Is Melatonin

Melatonin (5-methoxy-N-acetyltryptamine) is a hormone naturally produced by the pineal gland following a circadian rhythm — low during the day, elevated at night. Light exposure suppresses production; darkness triggers it. As a supplement, melatonin is the most studied sleep aid, with its mechanism well-characterized through MT1 and MT2 receptor signaling.

Unlike most supplements, melatonin acts on the same biological system as the body's own sleep signal. MT1 receptors promote sleep onset and REM sleep, while MT2 receptors handle circadian phase-shifting and NREM sleep. This dual mechanism makes melatonin uniquely effective for both sleep onset and circadian misalignment disorders.

What the Evidence Shows

Condition	Evidence	Key Finding
Sleep onset insomnia	Strong	Reduces SOL by ~7 min; optimal at 4mg, 3hrs before bed[1][2]
Jet lag	Strong	Cochrane: NNT = 2; 9/10 trials positive crossing 5+ time zones[3]
Preoperative anxiety	Strong	Cochrane: 27 RCTs; comparable to midazolam, fewer cognitive side effects[4]
Delayed sleep phase	Moderate	Low dose (0.5–1 mg) 3–5 hrs before desired bedtime advances circadian phase
Sleep maintenance	Moderate	Extended-release forms improve efficiency; AASM does not recommend for this
Shift work disorder	Insufficient	Evidence does not support melatonin for shift work specifically

Deep Dives by Condition

Forms Compared

Form	Onset	Best For
Immediate-release	15–90 min	Sleep onset difficulty
Extended-release	Gradual	Sleep maintenance; mimics natural profile
Sublingual	Rapid	Fast onset; bypasses first-pass metabolism
Prolonged-release (Circadin)	~2 hrs	Rx in EU; specifically for adults 55+

The 2024 dose-response meta-analysis found the conventional "2 mg at 30 minutes before bed" is suboptimal. 4 mg taken 3 hours before bedtime maximizes both sleep onset latency reduction and total sleep time increases.^[1]

Safety & Drug Interactions

Melatonin has an excellent safety record. A 2022 meta-analysis of 79 studies (3,861 participants) found no increase in serious adverse events even at doses of 10 mg or higher.^[5] Common side effects are mild: daytime sleepiness (1.66%), headache (0.74%), dizziness (0.74%). No evidence of dependence, withdrawal, or tolerance has been observed.^[2]

Drug Interactions

Drug	Interaction	Risk
Immunosuppressants	Melatonin stimulates immune function	High
Anticoagulants (warfarin)	Possible increased bleeding risk	Moderate
Diabetes medications	May lower blood sugar	Moderate
Sedatives / CNS depressants	Additive sedation	Moderate
Fluvoxamine (CYP1A2 inhibitor)	Dramatically increases melatonin levels	Moderate–High

Populations Requiring Caution

• Young children (0–6): Leading cause of unsupervised medication exposure in pediatric EDs^[6]
• Organ transplant recipients: Immune-stimulating properties could trigger rejection
• Pregnant/breastfeeding: Insufficient safety data
• Autoimmune conditions: May exacerbate symptoms

References

1. Cruz-Sanabria F, et al. "Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug." J Pineal Res. 2024;76(5):e12985. PubMed
2. Ferracioli-Oda E, et al. "Meta-analysis: melatonin for the treatment of primary sleep disorders." PLoS One. 2013;8(5):e63773. PubMed
3. Herxheimer A, Petrie KJ. "Melatonin for the prevention and treatment of jet lag." Cochrane Database Syst Rev. 2002. PubMed
4. Madsen BK, et al. "Melatonin for preoperative anxiety." Cochrane Database Syst Rev. 2020. 27 RCTs, 2,319 participants. PubMed
5. Menczel Schrire Z, et al. "Safety of higher doses of melatonin in adults." J Pineal Res. 2022. 79 studies, 3,861 participants. PubMed
6. Kracht CL, et al. "Melatonin Use in Young Children: A Systematic Review." JAMA Netw Open. 2026. PubMed
7. Lim S, et al. "Effects of exogenous melatonin: An umbrella review of meta-analyses." Pharmacol Res. 2022. PubMed

Related Guides